Navigation Links
Intarcia Announces Presentations of Three Clinical Abstracts at the 47th Annual Meeting of the European Association for the Study of Diabetes
Date:9/12/2011

HAYWARD, Calif., Sept. 12, 2011 /PRNewswire/ -- Intarcia Therapeutics, Inc. announced today the presentation of three clinical abstracts on ITCA 650 (DUROS® subcutaneous continuous delivery of exenatide) for the treatment of type 2 diabetes at the 47th Annual Meeting of the European Association for the Study of Diabetes in Lisbon, Portugal.  All three presentations are scheduled for Wednesday, September 14 in the Lisbon International Fair Convention Center.

(Logo: http://photos.prnewswire.com/prnh/20050301/SFTU126LOGO)

The first presentation, covering final 48 week results of the ITCA 650 phase 2 study will be delivered by Julio Rosenstock, MD, a principal investigator in the study from the Dallas Diabetes and Endocrine Center in Dallas, TX.

Abstract # 77

Oral Presentation Session OP 13 – GLP-1 receptor agonists

Wednesday, September 14, 2011 from 10:45 -- 12:15 in Roma Hall

Long-term, injection-free treatment with ITCA 650, a continuous subcutaneous delivery of exenatide via DUROS® device, leads to stable glycaemic and weight control for 48 weeks in metformin-treated type 2 diabetes

K. Luskey(1), J. Rosenstock(2), T. Alessi(1), R.R. Henry(3)

(1) Intarcia Therapeutics, Hayward, CA, USA, (2) Dallas Diabetes and Endocrine Center, Dallas, TX, USA, (3) University of California at San Diego, La Jolla, CA, USA.

Two other ITCA 650 presentations will occur in the poster session Wednesday afternoon.  Thomas Alessi, PhD, Intarcia's Vice President, Development will present the results of a patient satisfaction study applied to the ITCA 650 phase 2 study and Kenneth Luskey, MD, Intarcia's Chief Medical Officer will present an assessment of the pharmacokinetics and pharmacodynamics observed in the ITCA 650 phase 2 study.

Poster Session PS 063 GLP-1 receptor agonists: new
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
2. Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
3. Intarcia Presents Positive ITCA 650 Phase 2 Study Results for Type 2 Diabetes at EASD
4. Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014   Vestagen Technical ... the patient experience at hospitals. The myComfort™ line of ... active barrier fabric that is fluid repellant, breathable and ... inhibit the growth of bacteria on the fabric i ... clothing plays in the chain of transmission. We want ...
(Date:9/16/2014)... , Sept. 16, 2014 Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... product to receive formal designation as a "Promising Innovative ... Scheme" (EAMS) launched in the UK in April 2014. ... process for early access approval under the EAMS.  ...
(Date:9/16/2014)... 2014 CorMedix Inc. ("CorMedix") (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... amendment and restatement of its outstanding Series C-2, ... warrants, as well as the warrants issued in ... to remove anti-dilution, price reset and certain change ...
Breaking Medicine Technology:New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
... 2011 Cellular Dynamics International (CDI) today announced the ... Blood demonstrating for the first time a methodology ... of banked blood samples through the creation of induced ... "Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent ...
... Advanced Sterilization Products (ASP) announced today the ... GLOSAIR™ Healthcare Environmental Decontamination – that provides effective, ... operating suites to reduce the risk of patient ... scientific consensus that the patient environment is a ...
Cached Medicine Technology:Cellular Dynamics International Unlocks the Potential of Banked Blood Samples 2ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 2ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 3ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 4ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 5
(Date:9/17/2014)... In honor of National Health IT Week Sept. ... professionals for gaining a competitive edge in the healthcare ... demand for qualified health IT professionals are at an ... differentiating factor when filling a position. The skill most ... clinical workflow and terminology experience. American Sentinel offers ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 On October ... wellness to the lineup at Techmanity, a celebration of ... next generation of tech events,” Techmanity will host the ... excited to join the ranks of Cisco, PayPal, Samsung, ... ever Silicon Valley Technology Conference. , Voom was created ...
(Date:9/17/2014)... Presence Technology, a multinational provider of ... 10.0, which incorporates significant enhancements to meet the ... The Contact Center Agents and Supervisors will have ... a better feel for the performance of their ... who requires additional coaching or mentoring to raise ...
(Date:9/16/2014)... (PRWEB) September 17, 2014 Top10BestSEOHosting.com ... announced the most recommended companies for the webmasters ... at affordable rates. , The senior spokesman ... http://www.arvixe.com/6883.html ), Bluehost and HostMonster are the excellent ... managed to provide a wide range of advanced ...
(Date:9/16/2014)... report a poorer experience of care during pregnancy and ... care, suggests a new study published today (17 September) ... Gynaecology ( BJOG ). , Differences in health ... many areas and have provided the focus for national ... , The Oxford University study, funded by the National ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:Top10BestSEOHosting.com: Arvixe Is One Of The Best SEO Hosting Suppliers 2Health News:A greater focus on socially disadvantaged women is needed to improve maternity care in England 2
... the most common form of brain cancer might fare better ... alone . ,Based on findings of the study it ... known as glioblastoma receive surgery to remove as much of ... The current study compared 573 patients with glioblastomas who were ...
... to a study in Journal of Dental Research, caries in ... ,A primary tooth can have caries for a wide ... socio-economic status, years of exposure to water fluoridation, disturbance to ... all these differences, can caries in primary teeth have long-term ...
... variant that may increase the risk of late-onset Alzheimer’s ... understanding of the disease and new prevention and treatment ... specific changes in the gene in a protein called ... ,In previous studies, researchers studied Alzheimer’s patients and ...
... recent issue of Journal of American Medical Association, researchers have ... in delaying the vaccination schedules of the children resulting in ... ,According to the latest study, most of the ... years of age in children often gets delayed due to ...
... people it was found that men who drank six cups ... 12 to 18 years, while women who drank that amount ... their study revealed an unequivocal evidence for an inverse and ... other risk factors. However researchers say the reasons for ...
... paper presented at American College of Cardiology, laughter can ... presenter of the paper Michael Miller, MD, director of ... medicine at the University of Maryland in Baltimore, had ... healthy and 150 people suffering cardiac problems. ,The ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: